Factor XI Inhibition for Atrial Fibrillation: Where Do We Stand?
S
Siddharth M. Patel
(TIMI Study Group, Cardiovascular Division, Brigham and Women’s Hospital, Boston, MA.)
R
Robert P. Giugliano
C
Christian T. Ruff
Article Details
Journal
Circulation
Volume / Issue
Vol. 151, Issue 20
Published
May 20, 2025
Pages
1433-1435
ISSN
0009-7322
Publisher
Lippincott Williams & Wilkins
Authors (3)
S
Siddharth M. Patel
TIMI Study Group, Cardiovascular Division, Brigham and Women’s Hospital, Boston, MA.
R
Robert P. Giugliano
C
Christian T. Ruff
Related Articles from this Journal
Occupational Radiation Safety in Electrophysiology During Pregnancy: Evaluating Uterine Radiation Doses During Catheter Ablations and Device Implantations
Johanna Mueller-Leisse, Henrike Aenne Katrin Hillmann et al.
Aug 2026
10.1161/circulationaha.126.080556
Response by Rogers et al to Letter Regarding, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”
Albert J. Rogers, Sabyasachi Bandyopadhyay et al.
Aug 2026
10.1161/circulationaha.126.080755
Clinical Cardiology at the Crossroads: Perspectives on the Next Era at <i>Circulation</i>
Jennifer E. Ho, Ryan J. Tedford
Aug 2026
10.1161/circulationaha.126.080205
ABHD11-Mediated mtDNA Transcription Restored Mitochondrial Function to Attenuate Cardiomyocyte Ferroptosis After Myocardial Infarction
Yu Liu, Yijin Chen et al.
Aug 2026
10.1161/circulationaha.125.078593
Letter by Li et al Regarding Article, “Deep Learning-Based Continuous QT Monitoring to Identify High-Risk Prolongation Events After Class III Antiarrhythmic Initiation”
Dong Li, Shuang Zhang et al.
Aug 2026
10.1161/circulationaha.126.079996